Rights and permissions
About this article
Cite this article
Gemcitabine plus carboplatin “attractive option” for poor-risk, advanced bladder cancer. Inpharma Wkly. 1462, 16 (2004). https://doi.org/10.2165/00128413-200414620-00038
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200414620-00038